In the US, Actoplus Met (metformin/pioglitazone systemic) is a member of the drug class antidiabetic combinations and is used to treat Diabetes, Type 2.
US matches:
- Actoplus Met
- Actoplus Met XR Extended-Release Tablets
- Actoplus Met XR
Ingredient matches for Actoplus Met
Metformin
Metformin hydrochloride (a derivative of Metformin) is reported as an ingredient of Actoplus Met in the following countries:
- United States
Pioglitazone
Pioglitazone hydrochloride (a derivative of Pioglitazone) is reported as an ingredient of Actoplus Met in the following countries:
- United States
International Drug Name Search
No comments:
Post a Comment